Evidence of oxidative stress in temporomandibular disorders: A pilot study

Journal of Oral Rehabilitation

Volumn 38, Issue 10, 2011, Pages 722-728

  Rodriguez de Sotillo D ^a   Velly, A M ^a,b,c   Hadley, M ^d   Fricton, J R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MINNESOTA STATE UNIVERSITY   (United States)

Author keywords

Biomarkers; Myalgia; Oxidative stress; Saliva; Temporomandibular disorders; Temporomandibular joint (TMJ)

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8-HYDROXY-2'-DEOXYGUANOSINE; ANTIOXIDANT; BIOLOGICAL MARKER; DEOXYGUANOSINE; DRUG DERIVATIVE; MALONALDEHYDE;

ADULT; ARTICLE; BLOOD; COMPARATIVE STUDY; FACE PAIN; FEMALE; HOSPITALIZATION; HUMAN; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PILOT STUDY; SALIVA; STATISTICAL MODEL; TEMPOROMANDIBULAR JOINT DISORDER;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; DEOXYGUANOSINE; FACIAL PAIN; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALONDIALDEHYDE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; PILOT PROJECTS; SALIVA; SEVERITY OF ILLNESS INDEX; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 80052559909     PISSN: 0305182X     EISSN: 13652842     Source Type: Journal    
DOI: 10.1111/j.1365-2842.2011.02216.x     Document Type: Article

References (27)

1. Sessle B, Bryant P, Dionne R. (eds) Temporomandibular Disorders and Related Pain Conditions. Seattle: IASP Press, 1995.
2. Richards R, McGregor N, Roberts T. Association between oxidative damage markers and self-reported temporomandibular dysfunction symptoms in patients with chronic fatigue syndrome. J. Chronic Fatigue Syndrome. 2005;12:45-61.
3. Halliwell B, Gutteridge JM. (eds) Free Radicals in Biology and Medicine. London: Oxford University Press, 2007.
4. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci. 1993;694:72-77.
5. Merry P, Winyard PG, Morris CJ, Grootveld M, Blake DR. Oxygen free radicals, inflammation, and synovitis: and synovitis: the current status. Ann Rheum Dis. 1989;48:864-870.
6. Milam SB, Zardeneta G, Schmitz JP. Oxidative stress and degenerative temporomandibular joint disease: a proposed hypothesis. J Oral Maxillofac Surg. 1998;56:214-223.
7. Moore S, Calder KA, Miller NJ, Rice-Evans CA. Antioxidant activity of saliva and periodontal disease. Free Radic Res. 1994;21:417-425.
8. Nagler RM, Klein I, Zarzhevsky N, Drigues N, Reznick AZ. Characterization of the differentiated antioxidant profile of human saliva. Free Radic Biol Med. 2002;32:268-277.
9. Ozgocmen S, Ozyurt H, Sogut S, Akyol O, Ardicoglu O, Yildizhan H. Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int. 2006;26:598-603.
10. Pabon A, Carmona J, Burgos LC, Blair S. Oxidative stress in patients with non-complicated malaria. Clin Biochem. 2003;36:71-78.
11. Kawai Y, Kubota E, Okabe E. Reactive oxygen species participation in experimentally induced arthritis of the temporomandibular joint in rats. J Dent Res. 2000;79:1489-1495.
12. Gremillion HA. Multidisciplinary diagnosis and management of orofacial pain. Gen Dent. 2002;50:178-186.
13. Draper HH, Csallany AS, Hadley M. Urinary aldehydes as indicators of lipid peroxidation in vivo. Free Radic Biol. 2000;29:1071-1077.
14. Draper HH, Hadley M. Malondialdehyde determination as index of lipid-peroxidation. Methods Enzymol. 1990;186:421-431.
15. Myers S, Kaimal S, Springsteen J, Ferreira J, Ko CC, Fricton J. Development of a national TMJ implant registry and repository - NIDCR's TIRR. Northwest Dent. 2007;86:13-18.
16. Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord. 1992;6:301-355.
17. Fricton JR. Musculoskeletal measures of orofacial pain. Anesth Prog. 1990;37:136-143.
18. Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992;50:133-149.
19. Abu-Hilal M, McPhail MJ, Marchand L, Johnson CD. Malondialdehyde and superoxide dismutase as potential markers of severity in acute pancreatitis. JOP. 2006;7:185-192.
20. Holvoet P, Collen D, Van de Werf F. Malondialdehyde-modified LDL as a marker of acute coronary syndromes. JAMA. 1999;281:1718-1721.
21. Chi CH, Shiesh SC, Lin XZ. Total antioxidant capacity and malondialdehyde in acute abdominal pain. Am J Emerg Med. 2002;20:79-82.
22. Bengtsson A, Henriksson KG, Jorfeldt L, Kagedal B, Lennmarken C, Lindstrom F. Primary fibromyalgia. A clinical and laboratory study of 55 patients. Scand J Rheumatol. 1986;15:340-347.
23. Bengtsson A, Henriksson KG, Larsson J. Reduced high-energy phosphate levels in the painful muscles of patients with primary fibromyalgia. Arthritis Rheum. 1986;29:817-821.
24. Hadley M, Draper HH. Isolation of a guanine-malondialdehyde adduct from rat and human urine. Lipids. 1990;25:82-85.
25. Rodriguez de Sotillo D, Hadley M. Polyunsaturated Fatty Acids and Oxidative Stress in a Model of Hepatic Steatosis, thr (fa/fa) Zucker Rat, In vivo Effect of Chlorogenic Acid. FASEB J. 2008;22:1034-1035.
26. Trevisani M, Siemens J, Materazzi S, Bautista DM, Nassini R, Campi B et al. 4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. PNAS. 2007;104:13519-13524.
27. Canakci CF, Cicek Y, Yildirim A, Sezer U, Canakci V. Increased levels of 8-hydroxydeoxyguanosine and malondialdehyde and its relationship with antioxidant enzymes in saliva of periodontitis patients. Eur J Dent. 2009;3:100-106.